Valeant Pharmaceuticals Faces New Investigation By SEC
Valeant Pharmaceuticals International Inc. is under investigation by the U.S. Securities and Exchange Commission, the company said Monday, shortly after announcing its CEO's return from medical leave, a generic-drug maker's challenge...To view the full article, register now.
Already a subscriber? Click here to view full article